跳至主要内容
临床试验/NCT01615965
NCT01615965Unknown不适用

Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer

Technical University of Munich2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2010年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
160
试验地点
2
主要终点
Biochemical recurrence free survival

研究概览

简要总结

The purpose of this study is to set up a model for detecting micrometastases in Lymph nodes of patients with prostate cancer by quantitative polymerase chain reaction and its impact on progression-free survival.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Histologically confirmed prostate cancer
  • Locally operable tumor
  • Negative bone scan (obligatory if Gleason Score > 7 or PSA > 20ng/ml
  • Karnofsky ≥ 80%
  • Age 18 - 75 years
  • Informed consent in written form
  • Sufficient hematologic, coagulatory and renal function
  • Compliant patient and geographic precondition for adequate follow-up given

排除标准

  • Manifest secondary tumor
  • Organ metastases on CT-scan /MRI or in Histology
  • Myocardial infarction or stroke within the last 6 months
  • Severe cardiovascular (Grade III - IV according to NYHA), pulmonary (pO2 < 60 mmHg), renal, hepatic oder hematopoetic impairment
  • Severe active or chronic infection (z.B. pos. HIV-Antibody-Test, HBs-Ag-detected in Serum and/ or chronic Hepatitis)
  • Severe psychiatric disease
  • Previous chemotherapy
  • Previous pelvine radiotherapy

结局指标

主要结局

Biochemical recurrence free survival

时间窗: 2 years

Influence of molecularbiologic micrometastases in lymph nodes on biochemical recurrence free survival in comparison with patients who have histopathologic macrometastases or no evidence of lymph node metastases

次要结局

  • Frequency of molecular detected lymph node micrometastases according to their topography(2 years)

研究者

发起方
Technical University of Munich
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Detection of Micrometastases in Lymph Nodes of... | 临床试验